Cost saving analysis of prediabetes intervention modalities in comparison with inaction using Markov state transition model-A multiregional case study.
Hussain Abdulrahman Al-OmarMarcin CzechTran Quang NamUlrike Gottwald-HostalekNikola VesicJames WhitehouseMaddy DawsonPublished in: Journal of diabetes (2024)
Metformin (ER) and lifestyle interventions for prediabetes offer promise for reducing T2D incidence. Metformin (ER) could reduce T2D patient numbers and health care costs, given concerns regarding adherence in the context of funding/reimbursement challenges for lifestyle interventions.
Keyphrases
- physical activity
- healthcare
- metabolic syndrome
- weight loss
- cardiovascular disease
- endoplasmic reticulum
- estrogen receptor
- randomized controlled trial
- breast cancer cells
- case report
- risk factors
- big data
- glycemic control
- artificial intelligence
- skeletal muscle
- insulin resistance
- clinical evaluation
- affordable care act